HYCU Delivers Industry-First Backup for Microsoft 365 and Cloud Services With 100% Data Control and Storage Efficiency 21-05-2025, 02:01

AKWEL: NET INCOME OF €24.2 MILLION IN 2024 3-04-2025, 22:45

Teva Presents New Phase 3 Efficacy, Safety and Tolerability Data from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable for Adult Patients Diagnosed with Schizophrenia 21-09-2024, 15:15